BIO-RAD LABORATORIES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q2 2024.
  • Bio Rad Laboratories, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.17B, a 86.3% decline year-over-year.
  • Bio Rad Laboratories, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$1.33B, a 209% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$637M, a 82.4% increase from 2022.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.63B, a 185% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $4.25B, a 11.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.33B -$2.17B -$1B -86.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$322M $384M +$315M +457% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-02
Q4 2023 -$637M $350M -$478M -57.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 -$159M $106M +$269M Jul 1, 2023 Sep 30, 2023 10-K 2024-02-16
Q2 2023 -$428M -$1.16B -$237M -25.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$191M $69M +$3.44B Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-02
Q4 2022 -$3.63B $828M +$2.4B Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 -$6.03B -$163M -$4.09B -104% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-16
Q2 2022 -$1.94B -$925M -$1.84B -201% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-16
Q1 2022 -$93.1M -$3.37B -$4.35B -444% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-16
Q4 2021 $4.25B -$1.57B -$2.41B -287% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-17
Q3 2021 $6.67B $3.93B +$2.61B +199% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-17
Q2 2021 $4.05B $917M -$49.6M -5.13% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-17
Q1 2021 $4.1B $980M +$294M +42.9% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-17
Q4 2020 $3.81B $839M +$286M +51.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-11
Q3 2020 $3.52B $1.31B +$1.57B Jul 1, 2020 Sep 30, 2020 10-K 2022-02-11
Q2 2020 $1.95B $966M +$368M +61.4% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-11
Q1 2020 $1.58B $686M -$179M -20.7% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-11
Q4 2019 $1.76B $554M +$1.38B Oct 1, 2019 Dec 31, 2019 10-K 2021-02-16
Q3 2019 $377M -$259M -$528M -196% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-16
Q2 2019 $905M $599M +$331M +123% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-16
Q1 2019 $574M $865M +$208M +31.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-16
Q4 2018 $366M -$829M -$911M -1102% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $1.28B $269M +$247M +1119% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 $1.03B $268M +$263M +5260% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 $767M $657M +$644M +5197% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 $122M $82.7M +$101M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $20.8M $22.1M +$5M +29.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-04-01
Q2 2017 $15.8M $5M -$11.6M -69.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-04-01
Q1 2017 $27.4M $12.4M +$1.4M +12.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-04-01
Q4 2016 $26M -$18.7M -$68.2M -138% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $94.2M $17.1M -$300K -1.72% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-16
Q2 2016 $94.5M $16.6M -$11.8M -41.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-16
Q1 2016 $106M $11M -$6.8M -38.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-16
Q4 2015 $113M $49.5M +$10.5M +26.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 $103M $17.4M +$5.9M +51.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $96.7M $28.4M -$3.2M -10.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 $99.9M $17.8M +$11.1M +166% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $88.8M $39M +$8.9M +29.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 $79.9M $11.5M +$18.6M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 $61.3M $31.6M -$3M -8.67% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 $64.3M $6.7M -$13.5M -66.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 $77.8M $30.1M -$11.9M -28.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 $89.7M -$7.1M -$49.7M -117% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 $139M $34.6M -$13.7M -28.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 $153M $20.2M -$10.8M -34.8% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 $164M $42M -$17.2M -29.1% Oct 1, 2012 Dec 31, 2012 10-K 2013-03-18
Q3 2012 $181M $42.6M -$3.27M -7.12% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $184M $48.3M +$8.34M +20.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $176M $31M -$2M -6.05% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $178M $59.2M -$8.7M -12.8% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 $187M $45.9M +$1.1M +2.46% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $186M $40M +$2M +5.26% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 $184M $33M -$1.9M -5.44% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q4 2010 $186M $67.9M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $44.8M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $38M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $34.9M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.